Class II MHC antigen processing in immune tolerance and inflammation.

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Major Histocompatibility Complex class II (MHC-II) presents peptide antigens to CD4 T cells, essential for immune responses.
• Antigen presentation pathways, including peptide loading by HLA-DM and HLA-DO, vary across different antigen-presenting cells (APCs).
• These pathways are influenced by APC type, developmental stage, and activation status.

Purpose of the Study:

• To investigate the cell-specific mechanisms governing peptide antigen presentation by MHC-II.
• To understand how variations in antigen processing and peptide exchange factors impact T cell recognition.
• To explore the role of these cell-specific factors in maintaining immune tolerance and in the development of autoimmunity.

Main Methods:

• Analysis of antigen uptake and processing pathways in diverse APC populations.
• Examination of HLA-DM and HLA-DO expression and function in different cellular contexts.
• Investigating the impact of cell state (developmental and activation) on MHC-II peptide repertoire.

Main Results:

• Significant differences in antigen processing and MHC-II loading were observed among various APC types.
• Cell-specific expression of peptide exchange factors (HLA-DM/DO) critically shapes the presented peptide repertoire.
• Inflammatory conditions can alter MHC-II presentation, leading to increased presentation of specific self-peptides.

Conclusions:

• Cell-specific factors are critical determinants of the MHC-II peptide repertoire, influencing immune surveillance.
• Dysregulation of these factors, particularly during inflammation, can compromise peripheral tolerance and contribute to autoimmunity.
• Targeting these cell-specific mechanisms may offer new therapeutic strategies for immune-related diseases.